Please try another search
Chemclin Diagnostics Co., Ltd. engages in the research and development, production, and sale of clinical immune chemiluminescence diagnostic reagents and instruments. Its products include LiCAA series of diagnostic reagents based on photo-induced chemiluminescence and CC series based on enzymatic chemiluminescence diagnostic reagents and instruments, primarily used for infectious diseases, such as hepatitis B, hepatitis C, AIDS, syphilis, hepatitis A, hepatitis E, etc.; and detection of tumor markers, thyroid hormones, reproductive endocrine hormones, cardiac markers, and inflammation. The company was founded in 2007 and is headquartered in Beijing, China.
Name | Age | Since | Title |
---|---|---|---|
Renqian Zhong | 60 | 2019 | Independent Director |
Jie Zhang | 69 | 2019 | Independent Director |
Hongbin Zhou | 49 | 2019 | Director |
Junjie Zhang | 45 | 2019 | Director |
Na Sun | 45 | 2019 | Independent Director |
Zifu Lian | 56 | 2022 | Chairman of the Board of Supervisory & Core Technical Personnel |
Yanling Huang | 49 | 2022 | CFO, Secretary & Director |
Lingling Mei | 42 | 2022 | Supervisory |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review